The global oncology platform OncoDaily has announced the selection of Dr. Khalid bin Jabr Al Thani, Chairman of the Board of Directors of the Qatar Cancer Society, among the Top 100 Most Influential Figures in Oncology for 2025, in recognition of his outstanding contributions to advancing cancer patient care, his leadership role in supporting public health policies, and his efforts to strengthen healthcare systems. The recognition also reflects his ongoing work in cancer awareness, patient advocacy, medical education, and support for scientific research.

This prestigious international recognition represents a high-level global honor that underscores the advanced position of the State of Qatar in the field of cancer control. It further highlights the influential global presence of Qatari healthcare leadership in shaping health policies and advancing oncology services in line with international best practices. The achievement also emphasizes the vital role played by the Qatar Cancer Society as an effective national model in patient support, community awareness, and the development of strategic local and international partnerships—contributing to the strengthening of Qatar’s presence on global oncology platforms and enhancing opportunities for cooperation and knowledge exchange with international institutions and organizations.

On this occasion, Dr. Khalid bin Jabr Al Thani expressed his great pride in this recognition, stressing that it represents an appreciation of collective national efforts in the fight against cancer rather than an individual achievement. He stated:
“This international selection reflects the confidence of the global medical community in the approach adopted by the State of Qatar in developing an integrated healthcare system that is centered on prevention, early detection, and advanced treatment, and that places the patient at the heart of care—supported by wise leadership that has made human health a top priority.”
“We view this recognition as a greater responsibility that motivates us to continue our efforts, further develop our programs and services, and strengthen national and international partnerships, ensuring the delivery of comprehensive and sustainable support for cancer patients, survivors, and their families, and contributing to improving their quality of life throughout the treatment journey and beyond recovery.” He added: